Per Stirling Capital Management, Llc. Regeneron Pharmaceuticals, Inc. Transaction History
Per Stirling Capital Management, Llc.
- $705 Billion
- Q4 2024
A detailed history of Per Stirling Capital Management, Llc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Per Stirling Capital Management, Llc. holds 720 shares of REGN stock, worth $484,992. This represents 0.07% of its overall portfolio holdings.
Number of Shares
720
Previous 723
0.41%
Holding current value
$484,992
Previous $760 Million
32.48%
% of portfolio
0.07%
Previous 0.11%
Shares
6 transactions
Others Institutions Holding REGN
# of Institutions
1,485Shares Held
84.8MCall Options Held
1.51MPut Options Held
1.48M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.26 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.69 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.76 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.25 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.19 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $72.2B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...